Loading…

Epidermal powder immunization of mice and monkeys with an influenza vaccine

Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the i...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2003-06, Vol.21 (21), p.2830-2836
Main Authors: Chen, Dexiang, Endres, Ryan, Maa, Yuh-Fun, Kensil, Charlotte R., Whitaker-Dowling, Patricia, Trichel, Anita, Youngner, Julius S., Payne, Lendon G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953
cites cdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953
container_end_page 2836
container_issue 21
container_start_page 2830
container_title Vaccine
container_volume 21
creator Chen, Dexiang
Endres, Ryan
Maa, Yuh-Fun
Kensil, Charlotte R.
Whitaker-Dowling, Patricia
Trichel, Anita
Youngner, Julius S.
Payne, Lendon G.
description Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.
doi_str_mv 10.1016/S0264-410X(03)00175-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18780160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X03001750</els_id><sourcerecordid>18780160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</originalsourceid><addsrcrecordid>eNqFkNFqFTEQhoNY7LH6CEpAFL1YnWSz2eyVSKlaWvBCBe9CTjLB1N3kNNltaZ_enJ6DBW96NcPw_T_DR8gLBu8ZMPnhO3ApGsHg11to3wGwvmvgEVkx1bcN75h6TFb_kEPytJQLAOhaNjwhh4z3g5JcrMjZySY4zJMZ6SZd142GaVpiuDVzSJEmT6dgkZro6JTiH7wp9DrMv-uBhujHBeOtoVfG2hDxGTnwZiz4fD-PyM_PJz-Ovzbn376cHn86b6zoYG7W_Rr9ugXVD2iF4ODsIIy3vjWMGy-Aqw6tlOC9QHBOciWZV171Dmuma4_Im13vJqfLBcusp1AsjqOJmJaiqwJVFUEFX_0HXqQlx_qbZmKQUqhBsUp1O8rmVEpGrzc5TCbfaAZ661rfudZbkRpafedab9tf7tuX9YTuPrWXW4HXe8AUa0afTbSh3HNCyW6QvHIfdxxWaVcBsy42YLToQkY7a5fCA6_8BdNNmzY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1496648981</pqid></control><display><type>article</type><title>Epidermal powder immunization of mice and monkeys with an influenza vaccine</title><source>Elsevier</source><creator>Chen, Dexiang ; Endres, Ryan ; Maa, Yuh-Fun ; Kensil, Charlotte R. ; Whitaker-Dowling, Patricia ; Trichel, Anita ; Youngner, Julius S. ; Payne, Lendon G.</creator><creatorcontrib>Chen, Dexiang ; Endres, Ryan ; Maa, Yuh-Fun ; Kensil, Charlotte R. ; Whitaker-Dowling, Patricia ; Trichel, Anita ; Youngner, Julius S. ; Payne, Lendon G.</creatorcontrib><description>Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(03)00175-0</identifier><identifier>PMID: 12798624</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adjuvant ; Adjuvants, Immunologic - administration &amp; dosage ; Administration, Cutaneous ; Animals ; Antibodies, Viral - blood ; Biological and medical sciences ; Cholera ; Cholera Toxin - immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Fundamental and applied biological sciences. Psychology ; Hemagglutination Inhibition Tests ; Immune system ; Immunity, Mucosal ; Immunization ; Immunogenicity ; Influenza ; Influenza Vaccines - administration &amp; dosage ; Influenza Vaccines - immunology ; Injection ; Injections, Intramuscular ; Macaca mulatta ; Methods ; Mice ; Mice, Inbred BALB C ; Microbiology ; Monkeys &amp; apes ; Mortality ; Mucosal antibody ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - prevention &amp; control ; Powders ; Primate ; Rodents ; Saponins - administration &amp; dosage ; Saponins - immunology ; Species Specificity ; Toxins ; Vaccination - methods ; Vaccine ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies ; Virology ; Viruses ; Waterborne diseases</subject><ispartof>Vaccine, 2003-06, Vol.21 (21), p.2830-2836</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jun 20, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</citedby><cites>FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14865962$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12798624$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Dexiang</creatorcontrib><creatorcontrib>Endres, Ryan</creatorcontrib><creatorcontrib>Maa, Yuh-Fun</creatorcontrib><creatorcontrib>Kensil, Charlotte R.</creatorcontrib><creatorcontrib>Whitaker-Dowling, Patricia</creatorcontrib><creatorcontrib>Trichel, Anita</creatorcontrib><creatorcontrib>Youngner, Julius S.</creatorcontrib><creatorcontrib>Payne, Lendon G.</creatorcontrib><title>Epidermal powder immunization of mice and monkeys with an influenza vaccine</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.</description><subject>Adjuvant</subject><subject>Adjuvants, Immunologic - administration &amp; dosage</subject><subject>Administration, Cutaneous</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>Cholera</subject><subject>Cholera Toxin - immunology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Immune system</subject><subject>Immunity, Mucosal</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Influenza</subject><subject>Influenza Vaccines - administration &amp; dosage</subject><subject>Influenza Vaccines - immunology</subject><subject>Injection</subject><subject>Injections, Intramuscular</subject><subject>Macaca mulatta</subject><subject>Methods</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microbiology</subject><subject>Monkeys &amp; apes</subject><subject>Mortality</subject><subject>Mucosal antibody</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Powders</subject><subject>Primate</subject><subject>Rodents</subject><subject>Saponins - administration &amp; dosage</subject><subject>Saponins - immunology</subject><subject>Species Specificity</subject><subject>Toxins</subject><subject>Vaccination - methods</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</subject><subject>Virology</subject><subject>Viruses</subject><subject>Waterborne diseases</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkNFqFTEQhoNY7LH6CEpAFL1YnWSz2eyVSKlaWvBCBe9CTjLB1N3kNNltaZ_enJ6DBW96NcPw_T_DR8gLBu8ZMPnhO3ApGsHg11to3wGwvmvgEVkx1bcN75h6TFb_kEPytJQLAOhaNjwhh4z3g5JcrMjZySY4zJMZ6SZd142GaVpiuDVzSJEmT6dgkZro6JTiH7wp9DrMv-uBhujHBeOtoVfG2hDxGTnwZiz4fD-PyM_PJz-Ovzbn376cHn86b6zoYG7W_Rr9ugXVD2iF4ODsIIy3vjWMGy-Aqw6tlOC9QHBOciWZV171Dmuma4_Im13vJqfLBcusp1AsjqOJmJaiqwJVFUEFX_0HXqQlx_qbZmKQUqhBsUp1O8rmVEpGrzc5TCbfaAZ661rfudZbkRpafedab9tf7tuX9YTuPrWXW4HXe8AUa0afTbSh3HNCyW6QvHIfdxxWaVcBsy42YLToQkY7a5fCA6_8BdNNmzY</recordid><startdate>20030620</startdate><enddate>20030620</enddate><creator>Chen, Dexiang</creator><creator>Endres, Ryan</creator><creator>Maa, Yuh-Fun</creator><creator>Kensil, Charlotte R.</creator><creator>Whitaker-Dowling, Patricia</creator><creator>Trichel, Anita</creator><creator>Youngner, Julius S.</creator><creator>Payne, Lendon G.</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20030620</creationdate><title>Epidermal powder immunization of mice and monkeys with an influenza vaccine</title><author>Chen, Dexiang ; Endres, Ryan ; Maa, Yuh-Fun ; Kensil, Charlotte R. ; Whitaker-Dowling, Patricia ; Trichel, Anita ; Youngner, Julius S. ; Payne, Lendon G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adjuvant</topic><topic>Adjuvants, Immunologic - administration &amp; dosage</topic><topic>Administration, Cutaneous</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>Cholera</topic><topic>Cholera Toxin - immunology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Immune system</topic><topic>Immunity, Mucosal</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Influenza</topic><topic>Influenza Vaccines - administration &amp; dosage</topic><topic>Influenza Vaccines - immunology</topic><topic>Injection</topic><topic>Injections, Intramuscular</topic><topic>Macaca mulatta</topic><topic>Methods</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microbiology</topic><topic>Monkeys &amp; apes</topic><topic>Mortality</topic><topic>Mucosal antibody</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Powders</topic><topic>Primate</topic><topic>Rodents</topic><topic>Saponins - administration &amp; dosage</topic><topic>Saponins - immunology</topic><topic>Species Specificity</topic><topic>Toxins</topic><topic>Vaccination - methods</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</topic><topic>Virology</topic><topic>Viruses</topic><topic>Waterborne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Dexiang</creatorcontrib><creatorcontrib>Endres, Ryan</creatorcontrib><creatorcontrib>Maa, Yuh-Fun</creatorcontrib><creatorcontrib>Kensil, Charlotte R.</creatorcontrib><creatorcontrib>Whitaker-Dowling, Patricia</creatorcontrib><creatorcontrib>Trichel, Anita</creatorcontrib><creatorcontrib>Youngner, Julius S.</creatorcontrib><creatorcontrib>Payne, Lendon G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Dexiang</au><au>Endres, Ryan</au><au>Maa, Yuh-Fun</au><au>Kensil, Charlotte R.</au><au>Whitaker-Dowling, Patricia</au><au>Trichel, Anita</au><au>Youngner, Julius S.</au><au>Payne, Lendon G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidermal powder immunization of mice and monkeys with an influenza vaccine</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2003-06-20</date><risdate>2003</risdate><volume>21</volume><issue>21</issue><spage>2830</spage><epage>2836</epage><pages>2830-2836</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12798624</pmid><doi>10.1016/S0264-410X(03)00175-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2003-06, Vol.21 (21), p.2830-2836
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_18780160
source Elsevier
subjects Adjuvant
Adjuvants, Immunologic - administration & dosage
Administration, Cutaneous
Animals
Antibodies, Viral - blood
Biological and medical sciences
Cholera
Cholera Toxin - immunology
Enzyme-Linked Immunosorbent Assay
Female
Fundamental and applied biological sciences. Psychology
Hemagglutination Inhibition Tests
Immune system
Immunity, Mucosal
Immunization
Immunogenicity
Influenza
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
Injection
Injections, Intramuscular
Macaca mulatta
Methods
Mice
Mice, Inbred BALB C
Microbiology
Monkeys & apes
Mortality
Mucosal antibody
Orthomyxoviridae Infections - immunology
Orthomyxoviridae Infections - prevention & control
Powders
Primate
Rodents
Saponins - administration & dosage
Saponins - immunology
Species Specificity
Toxins
Vaccination - methods
Vaccine
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies
Virology
Viruses
Waterborne diseases
title Epidermal powder immunization of mice and monkeys with an influenza vaccine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A33%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidermal%20powder%20immunization%20of%20mice%20and%20monkeys%20with%20an%20influenza%20vaccine&rft.jtitle=Vaccine&rft.au=Chen,%20Dexiang&rft.date=2003-06-20&rft.volume=21&rft.issue=21&rft.spage=2830&rft.epage=2836&rft.pages=2830-2836&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/S0264-410X(03)00175-0&rft_dat=%3Cproquest_cross%3E18780160%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-b7befb30879ec4420dc94afcf3a12af40285ec660ff4e0dd62861f8f87de87953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1496648981&rft_id=info:pmid/12798624&rfr_iscdi=true